Related references
Note: Only part of the references are listed.Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Jeffrey D. Greenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
Atsushi Ogata et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis
Tracey E. Toms et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
Elena Myasoedova et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice
Ingo Hilgendorf et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
An Oral Syk Kinase Inhibitor in the Treatment of Rheumatoid Arthritis A Three-Month Randomized, Placebo-Controlled, Phase II Study in Patients With Active Rheumatoid Arthritis That Did Not Respond to Biologic Agents
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2011)
Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis
Daniel H. Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis
Jean-Frederic Boyer et al.
JOINT BONE SPINE (2011)
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2011)
Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
Shin-ya Kawashiri et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Phase II Study of Tofacitinib (CP-690,550) Combined With Methotrexate in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Yoshiya Tanaka et al.
ARTHRITIS CARE & RESEARCH (2011)
Systematic Review and Meta-Analysis: Anti-Tumor Necrosis Factor α Therapy and Cardiovascular Events in Rheumatoid Arthritis
Cheryl Barnabe et al.
ARTHRITIS CARE & RESEARCH (2011)
The Role of Immune Complexes in Atherogenesis
Dayangku Fatiha Pengiran Burut et al.
ANGIOLOGY (2010)
Effect of rheumatoid factor on mortality and coronary heart disease
Gunnar Tomasson et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Selective Estrogen Receptor α Agonist Org 37663 Induces Estrogenic Effects but Lacks Antirheumatic Activity
Ronald F. van Vollenhoven et al.
ARTHRITIS AND RHEUMATISM (2010)
Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment
Will Foster et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2010)
Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
Norihiro Nishimoto et al.
MODERN RHEUMATOLOGY (2010)
Methotrexate-how does it really work?
Edwin S. L. Chan et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis.
Michael E. Weinblatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases
Olaf Schultz et al.
PLOS ONE (2010)
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2010)
Association Between Anti-Cyclic Citrullinated Peptide Antibodies and Ischemic Heart Disease in Patients With Rheumatoid Arthritis
Francisco Javier Lopez-Longo et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Progressive Multifocal Leukoencephalopathy Following Rituximab Treatment in a Patient With Rheumatoid Arthritis
R. M. Fleischmann
ARTHRITIS AND RHEUMATISM (2009)
The Safety and Efficacy of a JAK Inhibitor in Patients With Active Rheumatoid Arthritis Results of a Double-Blind, Placebo-Controlled Phase IIa Trial of Three Dosage Levels of CP-690,550 Versus Placebo
Joel M. Kremer et al.
ARTHRITIS AND RHEUMATISM (2009)
Inflammatory Mediators and Premature Coronary Atherosclerosis in Rheumatoid Arthritis
Young Hee Rho et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Myles J. Lewis et al.
CIRCULATION (2009)
Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis
Gyoergy Kerekes et al.
CLINICAL RHEUMATOLOGY (2009)
Autoantibodies and the Risk of Cardiovascular Events
Kimberly P. Liang et al.
JOURNAL OF RHEUMATOLOGY (2009)
Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies
Christophe Meune et al.
RHEUMATOLOGY (2009)
Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis
P. A. Klimiuk et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Augmentation Index and Large-Artery Remodeling in Patients with Longstanding Rheumatoid Arthritis Compared with Healthy Controls
Herwig Pieringer et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis
Soko Setoguchi et al.
AMERICAN HEART JOURNAL (2008)
Role of inflammation in atherosclerosis associated with rheumatoid arthritis
Peter Libby
AMERICAN JOURNAL OF MEDICINE (2008)
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
Treatment of Rheumatoid Arthritis With a Syk Kinase Inhibitor A Twelve-Week, Randomized, Placebo-Controlled Trial
Michael E. Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2008)
The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis - A cohort and nested case-control analysis
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2008)
Atheroprotective Effects of Methotrexate on Reverse Cholesterol Transport Proteins and Foam Cell Transformation in Human THP-1 Monocyte/Macrophages
Allison B. Reiss et al.
ARTHRITIS AND RHEUMATISM (2008)
Short-Term Improvement of Endothelial Function in Rituximab-Treated Rheumatoid Arthritis Patients Refractory to Tumor Necrosis Factor α Blocker Therapy
Carlos Gonzalez-Juanatey et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Does tumor necrosis factor a inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
Joachim Listing et al.
ARTHRITIS AND RHEUMATISM (2008)
Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis
Tracey M. Farragher et al.
ARTHRITIS AND RHEUMATISM (2008)
Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis
Ignatios Ikonomidis et al.
CIRCULATION (2008)
The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006
Marc C. Hochberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
Malini Bajpai et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Inverse Association Between Obesity and Antinuclear Antibodies in Women
Delia Almeida Gonzalez et al.
JOURNAL OF RHEUMATOLOGY (2008)
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
Antonio Naranjo et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis
R. Gerli et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis
Edward Keystone et al.
ARTHRITIS AND RHEUMATISM (2007)
Heart failure among younger rheumatoid arthritis and Crohns patients exposed to TNF-α antagonists
J. R. Curtis et al.
RHEUMATOLOGY (2007)
Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis - Results of eighteen years of followup from the Early Rheumatoid Arthritis Study
D. L. Mattey et al.
ARTHRITIS AND RHEUMATISM (2007)
Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register
Tracey M. Farragher et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists
Jennifer Cole et al.
RHEUMATOLOGY INTERNATIONAL (2007)
The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
Calin Popa et al.
JOURNAL OF LIPID RESEARCH (2007)
Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis
C. Turesson et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
What effects might anti-TNF alpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNF alpha in cardiovascular pathophysiology
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Patterns of cardiovascular risk in rheumatoid arthritis
D. H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
R. N. Maini et al.
ARTHRITIS AND RHEUMATISM (2006)
Antirheumatic drug use and the risk of acute myocardial infarction
Samy Suissa et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
Vokko P. van Halm et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis
I del Rincón et al.
ARTHRITIS AND RHEUMATISM (2005)
Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis - A ten-year followup study of a primary care-based inception cohort
NJ Goodson et al.
ARTHRITIS AND RHEUMATISM (2005)
Arterial stiffness in chronic inflammatory diseases
MJ Roman et al.
HYPERTENSION (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiovascular Death in Rheumatoid Arthritis A Population-Based Study
Hilal Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study
KJ Warrington et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy
F Wolfe et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor α antibody
C Gonzalez-Juanatey et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
CD4+CD28-T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients
R Gerli et al.
CIRCULATION (2004)
The safety of anakinra in high-risk patients with active rheumatoid arthritis - Six-month observations of patients with comorbid conditions
MH Schiff et al.
ARTHRITIS AND RHEUMATISM (2004)
Explaining how high-grade systemic inflammation accelerates vascular risk in rheumatoid arthritis
N Sattar et al.
CIRCULATION (2003)
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects
I del Rincón et al.
ARTHRITIS AND RHEUMATISM (2003)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Predicting mortality in patients with rheumatoid arthritis
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2003)
HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis
C Gonzalez-Juanatey et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
DH Solomon et al.
CIRCULATION (2003)
The expansion of CD4(+)CD28(-) T cells in patients with rheumatoid arthritis
A Pawlik et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation
M Wong et al.
ARTHRITIS AND RHEUMATISM (2003)
Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis
D Hürlimann et al.
CIRCULATION (2002)
Mortality in early inflammatory polyarthritis - Cardiovascular mortality is increased in seropositive patients
NJ Goodson et al.
ARTHRITIS AND RHEUMATISM (2002)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients - A longitudinal study
P Boutouyrie et al.
HYPERTENSION (2002)
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes
G Liuzzo et al.
CIRCULATION (2000)
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
RBM Landewé et al.
LANCET (2000)
Share Paper
